This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1997 May 10;349(9062):1365.

doi: 10.1016/S0140-6736(97)24019-5.

Orally active prostacyclin analogue in primary pulmonary hypertension

Y Okano, T Yoshioka, A Shimouchi, T Satoh, T Kunieda

PMID: 9149701
DOI: 10.1016/S0140-6736(97)24019-5

Clinical Trial

Orally active prostacyclin analogue in primary pulmonary hypertension

Y Okano et al. Lancet. 1997.

. 1997 May 10;349(9062):1365.

doi: 10.1016/S0140-6736(97)24019-5.

Authors

Y Okano, T Yoshioka, A Shimouchi, T Satoh, T Kunieda

PMID: 9149701
DOI: 10.1016/S0140-6736(97)24019-5

Erratum in

Lancet 1997 Nov 8;350(9088):1406

No abstract available

PubMed Disclaimer

Similar articles

Beneficial hemodynamic effects of oral prostacyclin (PGI2) analogue, beraprost sodium, on a patient with primary pulmonary hypertension--a case report.
Hashida H, Hamada M, Shigematsu Y, Ikeda S, Kuwahara T, Kawakami H, Hara Y, Kodama K, Kohara K, Hiwada K. Hashida H, et al. Angiology. 1998 Feb;49(2):161-4. doi: 10.1177/000331979804900210. Angiology. 1998. PMID: 9482517
Hemodynamic and hormonal effects of beraprost sodium, an orally active prostacyclin analogue, in patients with secondary precapillary pulmonary hypertension.
Ono F, Nagaya N, Kyotani S, Oya H, Nakanishi N, Miyatake K. Ono F, et al. Circ J. 2003 May;67(5):375-8. doi: 10.1253/circj.67.375. Circ J. 2003. PMID: 12736472 Clinical Trial.
Emerging therapies for pulmonary hypertension: striving for efficacy and safety.
Kao PN, Faul JL. Kao PN, et al. J Am Coll Cardiol. 2003 Jun 18;41(12):2126-9. doi: 10.1016/s0735-1097(03)00468-6. J Am Coll Cardiol. 2003. PMID: 12821235 No abstract available.
[Therapy of severe pulmonary hypertension with prostacyclin and iloprost].
Matthes J, Mathen F, Herzig S, Wassermann K. Matthes J, et al. Dtsch Med Wochenschr. 2001 May 25;126(21):631-7. doi: 10.1055/s-2001-14422. Dtsch Med Wochenschr. 2001. PMID: 11413752 Review. German. No abstract available.
Prostacyclin therapy for pulmonary arterial hypertension: new directions.
Gomberg-Maitland M, Preston IR. Gomberg-Maitland M, et al. Semin Respir Crit Care Med. 2005 Aug;26(4):394-401. doi: 10.1055/s-2005-916154. Semin Respir Crit Care Med. 2005. PMID: 16121316 Review.

See all similar articles

Cited by

Vascular effects of prostacyclin: does activation of PPARδ play a role?
Katusic ZS, Santhanam AV, He T. Katusic ZS, et al. Trends Pharmacol Sci. 2012 Oct;33(10):559-64. doi: 10.1016/j.tips.2012.05.005. Epub 2012 Jun 23. Trends Pharmacol Sci. 2012. PMID: 22727878 Free PMC article. Review.
Drug treatment of pulmonary arterial hypertension: current and future agents.
Hoeper MM. Hoeper MM. Drugs. 2005;65(10):1337-54. doi: 10.2165/00003495-200565100-00003. Drugs. 2005. PMID: 15977967 Review.
Medium-term health-related quality of life in patients with pulmonary arterial hypertension treated with goal-oriented sequential combination therapy based on exercise capacity.
Hirashiki A, Adachi S, Okumura N, Nakano Y, Shimokata S, Shimizu A, Arai H, Toba K, Murohara T, Kondo T. Hirashiki A, et al. Health Qual Life Outcomes. 2019 Jun 14;17(1):103. doi: 10.1186/s12955-019-1178-x. Health Qual Life Outcomes. 2019. PMID: 31200710 Free PMC article.
Circulatory power and ventilatory power over time under goal-oriented sequential combination therapy for pulmonary arterial hypertension.
Hirashiki A, Adachi S, Nakano Y, Kamimura Y, Shimokata S, Takeshita K, Shimizu A, Toba K, Murohara T, Kondo T. Hirashiki A, et al. Pulm Circ. 2017 Apr-Jun;7(2):448-454. doi: 10.1177/2045893217703954. Epub 2017 Mar 21. Pulm Circ. 2017. PMID: 28597753 Free PMC article.
What is new in pediatric cardiology.
Gupta ML, Lantin-Hermoso MR, Rao PS. Gupta ML, et al. Indian J Pediatr. 2003 Jan;70(1):41-9. doi: 10.1007/BF02722744. Indian J Pediatr. 2003. PMID: 12619952 Review.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information